Pharma Pricing & Reimbursement, Vol. 9, No. 9, pp. 254-255, September 2004
2 Pages Posted: 8 Nov 2004
The US is using free trade agreements to address the global free rider problem in pharmaceutical R&D. This brief article outlines several objections to that approach.
Keywords: Free rider, pharmaceutical, USTR, trade agreements, R&D
JEL Classification: F12, F13, I18, K11, K19, K32, K33
Suggested Citation: Suggested Citation
Outterson, Kevin, Free Trade Against Free Riders?. Pharma Pricing & Reimbursement, Vol. 9, No. 9, pp. 254-255, September 2004. Available at SSRN: https://ssrn.com/abstract=615144